Clinical trial
Vaccination With Tumor mRNA in Metastatic Melanoma - Fixed Combination Versus…
NCT00204516 · University Hospital Tuebingen, Other · Completed
Key facts
| NCT number | NCT00204516 |
|---|---|
| Title | Vaccination With Tumor mRNA in Metastatic Melanoma - Fixed Combination Versus Individual Selection of Targeted Antigens |
| Official title | Pilot Study of Intradermal Vaccination of Melanoma Patients With a Fixed Combination of mRNAs Compared to an Individualized Selection After Analysis of Antigen Expression in Tumor Tissue |
| Lead sponsor | University Hospital Tuebingen, Other |
| Collaborators | German Research Foundation |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Malignant Melanoma |
| Intervention type | Biological, Drug |
| Interventions | mRNA coding for melanoma associated antigens, GM-CSF |
| Enrollment | 31 |
| Start date | Apr 1, 2007 |
| Primary completion | Aug 1, 2011 |
| Completion | Dec 1, 2012 |
| First posted | Sep 20, 2005 |
| Last update posted | Jan 16, 2013 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: